Proception Inc | Y Combinator
Winter 2025 batch; dexterous humanoid hands for research and future full humanoids.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:19 PM
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)Proception - Advanced Humanoid Hands Advanced humanoid hands that move, feel, and sense like human hands.
Raised $500K across 1 funding round. Latest: $500K Seed (Mar 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Seed (Mar 2025). Investors: Y Combinator. (High).
Hiring
1 hiring‑related row(s); role‑spam risk if mostly generic boards (Low).
Product / news
3 product/news‑styled row(s); headline risk without filings (High).
Verified facts
+1 more in Recent movement below
Winter 2025 batch; dexterous humanoid hands for research and future full humanoids.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
News · Thu, Jul 2, 03:35 PM · confidence 90%high quality
Wed, May 20, 06:19 PM · confidence 88%high quality
Wed, May 20, 06:19 PM · confidence 85%medium quality
Newest first · 5 event(s)
Source: News
Building advanced humanoid hands that move, feel, and sense like human hands.
Source: Careers page
Building advanced humanoid hands that move, feel, and sense like human hands.
Source: Homepage
Building advanced humanoid hands that move, feel, and sense like human hands.
Winter 2025 batch; dexterous humanoid hands for research and future full humanoids.
YC launch on dexterous humanoid hands.
1 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Building advanced humanoid hands that move, feel, and sense like human hands.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗2 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
Building advanced humanoid hands that move, feel, and sense like human hands.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗YC launch on dexterous humanoid hands.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
Winter 2025 batch; dexterous humanoid hands for research and future full humanoids.
Why it matters: Funding signal — Seed per this source; verify against the linked original before relying on it.
Open source ↗1 row(s)
Open roles and careers pages. Active hiring implies runway to spend and shows where the company is investing (engineering vs GTM vs ops).
Building advanced humanoid hands that move, feel, and sense like human hands.
Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.